Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.cbcpharma.com | |
Market Cap | 86.65 Cr. | |
Enterprise Value(EV) | 104.20 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.20 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 95.71 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 41.74 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 35.15 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 3.27 | Calculated using Price: 114.85 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.75 Cr. | 7,545,056 Shares |
FaceValue | 10 | |
About Chandra Bhagat Pharma Ltd. | ||
The company is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. It provides pharmaceuticals and special chemical products in the Indian and international market. It has wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market. |
1 Day |
|
|
1 Week |
|
+12.58% |
1 Month |
|
+19.64% |
3 Month |
|
-4.61% |
6 Month |
|
+7.24% |
1 Year |
|
+0.75% |
2 Year |
|
-8.67% |
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 6.89 | 5.38 | 9.33 | 13.44 | 6.46 | 1.67 | 0.78 | 3.19 | 3.49 | |
Return on Capital Employed (%) | 10.4 | 12.62 | 14.34 | 17.58 | 13.4 | 7.16 | 7.63 | 8.83 | 7.3 | |
Return on Assets (%) | 1.16 | 0.82 | 1.32 | 1.82 | 0.98 | 0.4 | 0.26 | 1.1 | 1.36 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 6 | 7 | 7 | 8 | 14 | 26 | 26 | 27 | 27 | 28 | |
Non Curr. Liab. | 0 | 0 | 11 | 21 | 16 | 15 | 13 | 8 | 6 | 6 | |
Curr. Liab. | 36 | 38 | 37 | 29 | 53 | 34 | 33 | 38 | 27 | 25 | |
Minority Int. | |||||||||||
Equity & Liab. | 42 | 44 | 56 | 58 | 83 | 75 | 72 | 72 | 61 | 60 | |
Non Curr. Assets | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 3 | |
Curr. Assets | 41 | 44 | 55 | 57 | 81 | 73 | 70 | 71 | 59 | 56 | |
Misc. Exp. not W/O | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Total Assets | 42 | 44 | 56 | 58 | 83 | 75 | 72 | 72 | 61 | 60 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 48 | 61 | 80 | 90 | 97 | 106 | 94 | 71 | 94 | 120 | |
Other Income | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | |
Total Income | 49 | 61 | 80 | 90 | 98 | 107 | 94 | 71 | 96 | 120 | |
Total Expenditure | -46 | -58 | -76 | -85 | -92 | -102 | -91 | -67 | -91 | -116 | |
PBIDT | 2 | 3 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | |
Interest | -2 | -2 | -4 | -4 | -4 | -4 | -3 | -4 | -3 | -2 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | |
Adjusted EPS | 8 | 10 | 8 | 2 | 3 | 1 | 0 | 0 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -9 | -6 | 4 | -7 | 8 | 12 | 5 | ||||
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Cash Fr. Finan. | 8 | 7 | -4 | 7 | -6 | -10 | -4 | ||||
Net Change | -1 | 0 | 0 | 0 | 2 | 3 | 1 | ||||
Cash & Cash Eqvt | 1 | 1 | 0 | 0 | 3 | 6 | 6 |
Mon, 01 Apr 2024
Closure of Trading Window Intimation for Closure of Trading Window. |
Thu, 09 Nov 2023
Board Meeting Outcome for Results For The Half Year Ended 30Th September 2023. Outcome of the board meeting held on 09th September 2023 for approval of un-audited financial result as on 30.09.2023. |
Thu, 09 Nov 2023
Financial Result As On 30.09.2023. Financial Result for half year ended 30th September 2023. |
Thu, 25 Apr 2024 |
High Delivery Percentage |
Opening at High |
Opening at Low |
Closing Above Previous High |
Opening at Low for 2 Days |